Dermata Financial Statements From 2010 to 2024
| DRMAW Stock | USD 0.01 0.00 0.00% |
Check Dermata Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dermata Therapeutics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Dermata financial statements analysis is a perfect complement when working with Dermata Therapeutics Valuation or Volatility modules.
Dermata |
Dermata Therapeutics Warrant Company EBITDA Analysis
Dermata Therapeutics' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Dermata Therapeutics EBITDA | 247.22 K |
Most of Dermata Therapeutics' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Dermata Therapeutics Warrant is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, Dermata Therapeutics Warrant reported earnings before interest,tax, depreciation and amortization of 247.22 K. This is 99.97% lower than that of the Biotechnology sector and 99.75% lower than that of the Health Care industry. The ebitda for all United States stocks is 99.99% higher than that of the company.
Dermata Therapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Dermata Therapeutics's current stock value. Our valuation model uses many indicators to compare Dermata Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Dermata Therapeutics competition to find correlations between indicators driving Dermata Therapeutics's intrinsic value. More Info.Dermata Therapeutics Warrant is rated # 3 in return on equity category among its peers. It is rated # 4 in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Dermata Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Dermata Therapeutics Financial Statements
Dermata Therapeutics investors use historical fundamental indicators, such as Dermata Therapeutics' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Dermata Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Dermata Stock Analysis
When running Dermata Therapeutics' price analysis, check to measure Dermata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermata Therapeutics is operating at the current time. Most of Dermata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dermata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermata Therapeutics' price. Additionally, you may evaluate how the addition of Dermata Therapeutics to your portfolios can decrease your overall portfolio volatility.